Health News Archive - February 02, 2009
General Assembly Votes Tuesday on SB 1116, and whether to cover cost of artificial limbs ROANOKE, Va., Feb.
SOUTH SAN FRANCISCO, Calif. and PT. RICHMOND, Calif., Feb. 2 /PRNewswire-FirstCall/ -- Transcept Pharmaceuticals, Inc. (Nasdaq: TSPT) today announced the completion of its merger with Novacea, Inc.
ROCKVILLE, Md., Feb. 2 /PRNewswire-FirstCall/ -- Neuralstem, Inc.
MCKINNEY, Texas, Feb. 2 /PRNewswire-FirstCall/ -- Torchmark Corporation (NYSE: TMK) will release Fourth Quarter 2008 earnings after the market closes on Wednesday, February 4, 2009.
LA JOLLA, Calif., Feb. 2 /PRNewswire-FirstCall/ -- Transdel Pharmaceuticals, Inc.
LEUVEN, Belgium, Feb. 2 /PRNewswire-FirstCall/ -- A 74-year-old prostate cancer patient has become the first person in Belgium to be treated using a new, faster form of radiotherapy that extends more advanced care to more patients.
SAN DIEGO, Feb. 2 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced it will report results for its fourth quarter and year ended December 31, 2008 after the market closes on Wednesday, February 11, 2009. Alan D.
IRVINE, Calif., Feb. 2 /PRNewswire/ -- EDI Health Group, Inc. (EHG), a provider of enhanced connectivity, streamlined technology and transaction solutions for patients, payers and providers in the dental industry, today announced an agreement with Quality Systems, Inc.
Pioneer in Women's Health Marks 64 Years of Innovation and Growth SAN ANTONIO, Feb. 2 /PRNewswire/ -- Mission Pharmacal Company this year celebrates 64 years of excellence in manufacturing and distributing pharmaceutical products primarily for women's health.
RIDGEFIELD, Conn., Feb. 2 /PRNewswire/ -- Xmark Opportunity Partners, LLC ("Xmark"), the sole member of the investment manager of Xmark Opportunity Fund, L.P. and Xmark Opportunity Fund, Ltd., has, in the past, sent letters to the Board of Directors of Icagen, Inc.